AdaptX is a technology company.
AdaptX empowers clinical leaders to manage variation in care across treatments, workflows, and teams.
AdaptX has raised $19.0M across 4 funding rounds.
AdaptX has raised $19.0M in total across 4 funding rounds.
AdaptX is a Seattle-based medtech company that builds AI-driven software to help healthcare providers analyze electronic medical record (EMR) data, enabling clinical leaders to manage variation in care across treatments, workflows, and teams.[1][2][6] It addresses critical challenges like capacity constraints, revenue optimization, care quality, health equity, and sustainability by detecting patterns, trends, and inefficiencies in real-world data.[1][2][6] Serving hospitals and health systems such as Seattle Children's Hospital, Memorial Hermann, Children's Minnesota, and Kittitas Valley Healthcare, AdaptX has raised $21.16M in funding (most recently $10M in 2023, led by Cercano Management), employs over 40 people, and operates at Series B stage.[1][2]
The platform's self-serve tools allow clinicians to compare care approaches, identify outcome disparities, and drive improvements without relying on IT teams, fostering energy among surgeons and leaders to align on business goals.[2][6] This has led to demonstrated gains in quality, efficiency, and equity, expanding capacity to serve more patients in diverse settings from academic centers to rural communities.[2][6]
Founded in 2016 as MDmetrix by pediatric anesthesiologist Dr. Dan Low, AdaptX emerged from his real-world challenges at Seattle Children's Hospital, where he struggled to evaluate if a new drug improved outcomes in common surgeries compared to prior methods.[1][2] Low's firsthand experience highlighted the need for accessible data analysis to reduce clinical variation and enhance decision-making, prompting the company's pivot to AI-powered solutions.[2]
Early traction came from proving value in pediatric care, evolving into broader applications for health systems. By 2023, with over 40 employees (doubled from 2021), AdaptX secured $10M in Series B extension funding from investors including Cercano Management, Memorial Hermann, Morningside Ventures, Founders’ Co-Op, Fortson VC, Star Equity, and WRF Capital, fueling platform expansion and customer growth.[1][2]
AdaptX rides the AI in digital health wave, targeting clinical variation management amid rising healthcare costs, staffing shortages, and equity demands—exacerbated by post-pandemic EMR data explosion.[1][2] Timing aligns with health systems' shift to value-based care, where real-world evidence from AI analytics influences reimbursements and regulations like CMS equity mandates.[6]
Market forces favor it: explosive EMR adoption (e.g., Epic, Cerner), AI maturity for healthcare (post-ChatGPT hype), and investor interest in medtech efficiency tools, as seen in $10M raise amid Series B funding.[1][2] AdaptX influences the ecosystem by democratizing data for frontline clinicians, reducing reliance on consultants, and enabling scalable improvements—positioning it in expert collections like Digital Health and AI applications in pediatrics.[1]
AdaptX is poised for accelerated adoption as health systems prioritize AI for operational resilience, with potential expansion into new verticals like maternal health or chronic care via real-time equity insights.[2][6] Trends like multimodal AI integration with wearables/genomics and regulatory pushes for outcome transparency will amplify its edge, while partnerships (e.g., Memorial Hermann) could drive enterprise-scale deployments.[2]
Its influence may evolve from niche pediatric innovator to standard tool in clinical management stacks, especially if it sustains momentum post-2023 funding amid competitive AI health analytics. This builds on its core strength: turning clinician frustration into data-driven wins, much like Dr. Low's original spark at Seattle Children's.
AdaptX has raised $19.0M in total across 4 funding rounds.
AdaptX's investors include Founders' Co-op, Vulcan Capital, Bukola Ojo, Brick & Mortar Ventures, Haystack, Math Capital, Moshe Lifschitz.
AdaptX has raised $19.0M across 4 funding rounds. Most recently, it raised $10.0M Series B in September 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2023 | $10.0M Series B | Founders' Co-op, Vulcan Capital, Bukola Ojo | |
| Jul 1, 2021 | $6.0M Series A | Founders' Co-op, Vulcan Capital, Bukola Ojo | |
| May 1, 2019 | $3.0M Seed | Brick & Mortar Ventures, Founders' Co-op, Haystack, Math Capital, Moshe Lifschitz | |
| May 1, 2018 | $10K Seed |